The U.S. Pharmacopeia (USP) has opened the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its launch of a suite of R&D analytical solutions.
Phlow, a Virginia-based CDMO, has teamed with the nonprofit U.S. Pharmacopeia (USP) to open a new drug development lab to focus on research and development of new drugs and advanced manufacturing technologies.
Pretoria, 14 January 2022- The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MOU) with the U.S. Pharmacopeia (USP) to help expand the availability of health products, including medical devices, that are safe, efficacious, and of assured quality.
Rockville, Md., December 16, 2021 – The American Medical Association (AMA), American Society of Anesthesiologists (ASA), American Society of Health-System Pharmacists (ASHP), Association for Clinical Oncology (ASCO), and the United States Pharmacopeia (USP) today released a series of policy and marketplace recommendations to address significant challenges in our nation’s drug supply chain that have been exacerbated by the COVID-19 pandemic.
Rockville, MD, December 1, 2021 – USP announced that its new General Chapter <1469> Nitrosamines Impurities became official today in the United States Pharmacopeia—National Formulary. This new standard supports manufacturers and regulators by providing guidance on assessing materials for nitrosamine presence, establishing control strategies for these impurities and ensuring the performance of analytical procedures to monitor nitrosamine levels in drug products.
Rockville – September 24, 2021 The U.S. Pharmacopeia (USP), Vizient, and Angels for Change collaborated to better characterize drug shortages through machine learning and advanced analytics. Each of the organizations independently leads efforts to strengthen the resiliency of the pharmaceutical supply chain. By combining USP’s Medicine Supply Map, Angels for Change’s network of clinical and market experts, and Vizient’s strategic sourcing and analytics expertise for essential medications, the collective team has the capability and data to explore novel drug shortage insights in the pediatric oncology space.
Rockville, MD, September 13, 2021 – The U.S. Pharmacopeia (USP) announces the launch of a new department, the Office of Organizational Culture, Equity and Inclusive Excellence (Equity Office). Headed by Chief Equity Officer (CEqO) and Senior Advisor to the CEO, Debra Joy Pérez, Ph.D. (she/her/ella), the Equity Office will shape and implement all diversity, equity, inclusion and belonging (DEIB) programs and initiatives.
Rockville, Md., September 1, 2021 — USP published revisions to Compounding General Chapters <795> Pharmaceutical Compounding – Nonsterile Preparations and <797> Pharmaceutical Compounding – Sterile Preparations for an extended 150-day public comment period—until January 31, 2022.
Rockville, MD, August 17, 2021 – The U.S. Pharmacopeia (USP) released two new resources that can help countries build foundational frameworks and broaden efforts to help ensure and maintain the quality of COVID-19 vaccines as they travel through the supply chain, identify substandard and falsified vaccines, and aid distribution efficiencies in geographies around the world.
(Washington, D.C.) — The Pharmaceutical Supply and Payment Chain Coalition issued the following statement in response to the Administration’s 100-day review of the actions needed to address vulnerabilities in our nation’s pharmaceutical supply chain and what measures need to be taken in order to strengthen the security of the domestic drug supply (“Building Resilient Supply Chains, Revitalizing American Manufacturing, and Fostering Broad-based Growth”).